Myrbetriq (mirabegron extended-release tablets) is now approved for treatment of neurogenic detrusor overactivity, common in patients with spina bifida, in children 3 years and older, the […]
Allowing Ontario pharmacists to prescribe for minor ailments could save the province $42 million a year, according to a new study from researchers at the University […]
An international team of researchers has developed a mathematical model for predicting how bad an upcoming hay fever season will be. In their paper published in […]
An international research team led by Oxford University scientists has developed a portable test for antibodies that fight the novel coronavirus that causes COVID-19.